Инсульт является гетерогенным синдромом и определение факторов риска, тактики лечения и профилактики зависят от конкретного патогенеза заболевания. Факторы риска ишемического и геморрагического инсульта схожи, но в то же время имеют различия. Отдельно обсуждается понятие триггеров инсульта. Кроме того, для глубокого понимания патогенетических механизмов и разработки новых стратегий терапии и профилактики необходимо понимание генетических механизмов риска развития инсульта. Генетические факторы могут быть более поддающимися изменению, чем считалось ранее. Для снижения бремени инсульта необходимы своевременное выявление и контроль модифицируемых факторов риска.
Pathogenesis of ischemic stroke is actively involved in the system of innate immunity. Under conditions of cerebral ischemia, a number of biologically active substances are released that interact with innate immunity receptors, in particular TLR2 and TLR4, which exacerbate inflammation in brain tissue. Identification of predictor markers at the level of the innate immunity system may foresee the clinical course of ischemic stroke and ensure timely treatment. Our objective was to study expression of TLR2 and TLR4 receptors in peripheral blood leukocytes in patients with ischemic stroke in the dynamics of the disease. 27 people were included in the study. The main group consisted of patients with ischemic stroke of varying severity (n = 19). Patients of the main group were divided into two subgroups: with an NIHSS index value of < 10 (n = 10) and > 10 (n = 9). The control group included healthy donors with no history of acute and chronic inflammatory diseases (n = 8). Peripheral blood leukocytes were used as the test material. To determine expression of the TLR2 and TLR4 genes, RT-PCR in real time was used. Surface expression of TLRs was determined by flow cytometry. A study of the TLR2 and TLR4 gene expression showed that on the 1st, 3rd and 7th day post-stroke, the TLR4 gene expression in patients was significantly increased, when compared to the control group (p < 0.01), whereas TLR2 gene expression on the 3rd day of the disease was not statistically different from the control group. A study of surface expression of receptors showed that the average TLR2 fluorescence intensity on the patients’ peripheral blood monocytes was significantly increased on the 1st and 3rd day of disease when compared to the control group. The surface expression of TLR4 on monocytes has a statistically significant increase only on day 7. Assessment of surface expression of TLRs in subgroups with different severity values by NIHSS showed that patients with a NIHSS index > 10 had a significantly higher level of surface of TLR2 expression over the observation period, while the largest difference in TLR4 expression in the subgroups was observed on the 1st day of the disease (p < 0.05). Patients with ischemic stroke showed an increase in TLR2 and TLR4 expression at the gene and protein level, compared to healthy donors. These indices can be considered possible predictors for clinical prognosis of ischemic stroke.
21 March 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Objective. To study the prognostic value of von Willebrand factor (vWF) in peracute and acute periods of cardioembolic stroke (CES) in patients receiving unfractionated (UFH) and low molecular weight heparin (LMWH). Material and methods. Thirty patients with CES receiving UFH/LMWH and acetylsalicylic acid were examined. The comparison group included 15 patients with non-cardioembolic stroke without heparin therapy. On Days 2—3 and 7—10 from the disease onset, patients were evaluated using the NIHSS and HAS-BLED scales; also, brain CT, Doppler ultrasound, echocardiography, complete blood count and blood chemistry, vWF measurement, and induced platelet aggregation test with ristocetin, arachidonic acid, and collagen were performed. Results. During LMWH therapy in the peracute period, increased platelet aggregation with ristocetin (p=0.038) and vWF levels (p=0.017) were found versus the comparison group. A correlation between vWF level and platelet aggregation with collagen was identified (p=0.010, r=0.461). No inhibition of platelet function with ristocetin was observed during the entire period of therapy with both LMWH and UFH. During LMWH treatment, increased platelet activity with ristocetin was observed in the acute period, compared with patients receiving UFH (p=0.007). There were no significant differences in the change in the vWF levels in patients with and without hematuria. There was a correlation between the HAS-BLED score and hematuria in the semiquantitative analysis of erythrocytes in urine (p=0.041, r=0.375), as well as a correlation between the vWF levels and the ASPECT score (p=0.001, r=–0.576). Conclusion. The concomitant use of heparin with antiplatelet agents, particularly with aspirin in CES, enhances its anticoagulant activity and inhibits platelets in the test with arachidonic acid. Continued high ristocetin- and collagen-induced platelet aggregation supports the use of vasoprotective agents activating metabolic processes in the walls of blood vessels to correct persistent endothelial dysfunction.
23 April 2024 in S.S. Korsakov Journal of Neurology and Psychiatry
Hemorrhagic transformation (HT) is a serious complication that worsens outcomes and increases mortality in patients with ischemic stroke (IS). HT can occur both spontaneously and after reperfusion therapy. Severe ischemic injury in IS is not sufficient in itself to cause HT; one of the key elements in its development is reperfusion. Delayed reperfusion in the area of severe ischemic injury mainly increases the likelihood of HT due to disruptions in the blood-brain barrier (BBB), which, in turn, play a key role in the formation of HT in the acute period of IS. Currently, perfusion CT and MRI are the most widely used imaging methods for assessing the patient’s condition and predicting clinical outcome. To assess the degree of ischemic injury, there are various neuroimaging indicators that reflect the level of ischemic damage in IS and can be used as predictors of HT. To date, the most reliable tools for assessing the risk of HT include very low cerebral blood volume (VLCBV), time to reach maximum concentration of contrast agent (Tmax), permeability surface-area product (PS), lesion volume in diffusion-weighted images (DWI), and poor collateral circulation.
3 September 2025 in S.S. Korsakov Journal of Neurology and Psychiatry
Objective. To study the polymorphism of 5 single nucleotide substitutions (SNPs) of the protocadherin gamma (PCDHG) and DIAPH1 genes, previously identified as a haploblock on chromosome 5 (chr5:140757301-140940025) and associated with the risk of ischemic stroke (IS) in patients of Western European origin, in a cohort of IS patients from the Russian ethnic group. Material and methods. Determination and study of allelic variants of 5 SNPs (rs17603019, rs11575963, PCDHG; rs251021, rs397327 and rs17524736;DIAPH1) was carried out in a group of IS patients and a control group, which included 331 and 222 subjects, respectively, 55 years of age or older. The functional recovery of patients after a stroke was assessed according to a modified Rankin scale. Results. The probability p-value for the haploblock was 0.019. From the haplotypes, the TTTTA haplotype (p=0.0039) was associated with the IS risk; at the individual level, SNPs rs251021 (p=0.0075) and rs397327 (p=0.0093;dominant model) of the DIAPH1 gene were also associated with the recovery of patients after stroke. Conclusion. The association of a 5-site haploblock with IS, established earlier in Western Europeans, was confirmed in the Eastern European cohort of Russian patients. It is assumed that the genes included in it can be considered candidate genes in relation to the risk of developing the disease and the functional recovery of patients after a stroke.
Neurofibromatosis (NF) is a hereditary disease characterized by the formation and growth of benign tumors of neuroectodermal origin. There are three main nosological forms: NF1, NF2, NF3. It is believed that the disease debuts in childhood and significantly reduces the life expectancy of patients. The main cause of death in middle age are cardiovascular diseases and malignant neoplasms. There are isolated publications on NF in patients over 60 years old. The relationship between NF and cardiorenal syndrome has not been sufficiently studied. The development of vasculitis with vasculopathy is described, which leads to narrowing and occlusion of the coronary, renal, cerebral and other arteries. The article presents a description of an 85-year-old patient with NF and the development of cardiorenal syndrome.